166 related articles for article (PubMed ID: 23391120)
1. A 75-year-old man with progressive bronchioalveolar carcinoma.
Baikadi M; Lovly C; Horn L; Reckamp KL; Noonan K; Laskin J; Morris GJ
Semin Oncol; 2013 Feb; 40(1):e1-8. PubMed ID: 23391120
[No Abstract] [Full Text] [Related]
2. [Importance of pathology research on lung adenocarcinoma].
Zhu XZ
Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):649-51. PubMed ID: 23302303
[No Abstract] [Full Text] [Related]
3. Concurrent molecular alterations in tumors with germ line epidermal growth factor receptor T790M mutations.
Thomas A; Xi L; Carter CA; Rajan A; Khozin S; Szabo E; Dennis PA; Giaccone G; Raffeld M
Clin Lung Cancer; 2013 Jul; 14(4):452-6. PubMed ID: 23540867
[No Abstract] [Full Text] [Related]
4. Bronchioloalveolar adenocarcinoma and pulmonary langerhans cell histiocytosis in a patient with MUTYH-associated polyposis.
von der Thüsen JH; van de Wetering MD; Westermann AM; Heideman DA; Thunnissen E
J Clin Oncol; 2011 Mar; 29(8):e188-90. PubMed ID: 21189386
[No Abstract] [Full Text] [Related]
5. Sorafenib in patients with advanced non-small cell lung cancer that harbor K-ras mutations: a brief report.
Smit EF; Dingemans AM; Thunnissen FB; Hochstenbach MM; van Suylen RJ; Postmus PE
J Thorac Oncol; 2010 May; 5(5):719-20. PubMed ID: 20421765
[No Abstract] [Full Text] [Related]
6. Mucinous bronchioloalveolar carcinoma with K-ras mutation arising in type 1 congenital cystic adenomatoid malformation: a case report with review of the literature.
Ishida M; Igarashi T; Teramoto K; Hanaoka J; Iwai M; Yoshida K; Kagotani A; Tezuka N; Okabe H
Int J Clin Exp Pathol; 2013; 6(11):2597-602. PubMed ID: 24228126
[TBL] [Abstract][Full Text] [Related]
7. Histology matters: individualizing treatment in non-small cell lung cancer.
Neal JW
Oncologist; 2010; 15(1):3-5. PubMed ID: 20086166
[TBL] [Abstract][Full Text] [Related]
8. Are there imaging characteristics associated with epidermal growth factor receptor and KRAS mutations in patients with adenocarcinoma of the lung with bronchioloalveolar features?
Glynn C; Zakowski MF; Ginsberg MS
J Thorac Oncol; 2010 Mar; 5(3):344-8. PubMed ID: 20087229
[TBL] [Abstract][Full Text] [Related]
9. Bronchioloalveolar neoplasia.
Kitamura H; Okudela K
Int J Clin Exp Pathol; 2010 Nov; 4(1):97-9. PubMed ID: 21228931
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary pleomorphic carcinoma: a clinicopathological study including EGFR mutation analysis.
Kaira K; Horie Y; Ayabe E; Murakami H; Takahashi T; Tsuya A; Nakamura Y; Naito T; Endo M; Kondo H; Nakajima T; Yamamoto N
J Thorac Oncol; 2010 Apr; 5(4):460-5. PubMed ID: 20107421
[TBL] [Abstract][Full Text] [Related]
11. Co-existence of positive MET FISH status with EGFR mutations signifies poor prognosis in lung adenocarcinoma patients.
Tanaka A; Sueoka-Aragane N; Nakamura T; Takeda Y; Mitsuoka M; Yamasaki F; Hayashi S; Sueoka E; Kimura S
Lung Cancer; 2012 Jan; 75(1):89-94. PubMed ID: 21733594
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor mutation and pathologic-radiologic correlation between multiple lung nodules with ground-glass opacity differentiates multicentric origin from intrapulmonary spread.
Chung JH; Choe G; Jheon S; Sung SW; Kim TJ; Lee KW; Lee JH; Lee CT
J Thorac Oncol; 2009 Dec; 4(12):1490-5. PubMed ID: 19844187
[TBL] [Abstract][Full Text] [Related]
13. Paxillin expression and amplification in early lung lesions of high-risk patients, lung adenocarcinoma and metastatic disease.
Mackinnon AC; Tretiakova M; Henderson L; Mehta RG; Yan BC; Joseph L; Krausz T; Husain AN; Reid ME; Salgia R
J Clin Pathol; 2011 Jan; 64(1):16-24. PubMed ID: 21045234
[TBL] [Abstract][Full Text] [Related]
14. Frequency of EGFR and KRAS mutations in Japanese patients with lung adenocarcinoma with features of the mucinous subtype of bronchioloalveolar carcinoma.
Hata A; Katakami N; Fujita S; Kaji R; Imai Y; Takahashi Y; Nishimura T; Tomii K; Ishihara K
J Thorac Oncol; 2010 Aug; 5(8):1197-200. PubMed ID: 20661086
[TBL] [Abstract][Full Text] [Related]
15. Ciliated adenocarcinomas of the lung: a tumor of non-terminal respiratory unit origin.
Park WY; Kim MH; Shin DH; Lee JH; Choi KU; Kim JY; Park DY; Lee CH; Sol MY
Mod Pathol; 2012 Sep; 25(9):1265-74. PubMed ID: 22555174
[TBL] [Abstract][Full Text] [Related]
16. Lung adenocarcinoma with EGFR amplification has distinct clinicopathologic and molecular features in never-smokers.
Sholl LM; Yeap BY; Iafrate AJ; Holmes-Tisch AJ; Chou YP; Wu MT; Goan YG; Su L; Benedettini E; Yu J; Loda M; Jänne PA; Christiani DC; Chirieac LR
Cancer Res; 2009 Nov; 69(21):8341-8. PubMed ID: 19826035
[TBL] [Abstract][Full Text] [Related]
17. MET gene copy number in non-small cell lung cancer: molecular analysis in a targeted tyrosine kinase inhibitor naïve cohort.
Beau-Faller M; Ruppert AM; Voegeli AC; Neuville A; Meyer N; Guerin E; Legrain M; Mennecier B; Wihlm JM; Massard G; Quoix E; Oudet P; Gaub MP
J Thorac Oncol; 2008 Apr; 3(4):331-9. PubMed ID: 18379349
[TBL] [Abstract][Full Text] [Related]
18. Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer.
Ludovini V; Bianconi F; Pistola L; Chiari R; Minotti V; Colella R; Giuffrida D; Tofanetti FR; Siggillino A; Flacco A; Baldelli E; Iacono D; Mameli MG; Cavaliere A; Crinò L
J Thorac Oncol; 2011 Apr; 6(4):707-15. PubMed ID: 21258250
[TBL] [Abstract][Full Text] [Related]
19. Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib.
Miller VA; Riely GJ; Zakowski MF; Li AR; Patel JD; Heelan RT; Kris MG; Sandler AB; Carbone DP; Tsao A; Herbst RS; Heller G; Ladanyi M; Pao W; Johnson DH
J Clin Oncol; 2008 Mar; 26(9):1472-8. PubMed ID: 18349398
[TBL] [Abstract][Full Text] [Related]
20. KRAS mutation analysis helps to differentiate between pulmonary metastasis from colon adenocarcinoma in situ and primary lung adenocarcinoma.
Ortiz TM; Cohen DW; Kent MS; Jänne PA; Costa DB
J Thorac Oncol; 2011 Jan; 6(1):220-2. PubMed ID: 21178719
[No Abstract] [Full Text] [Related]
[Next] [New Search]
